Skip to main content

Table 1 Patient demographics and clinical characteristics

From: Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)

Demographics and clinical characteristics n = 2554
Age (years), mean (SD) 71.5 (9.9)
Gender (male), n (%) 1978 (77.4)
BMI, mean (SD) 25.9 (4.5)
Risk classification at diagnosis, n (%)
 High 1248 (48.9)
 Intermediate 1306 (51.2)
ECOG at initial NMIBC diagnosis, n (%)
 0 1209 (47.3)
 1 805 (31.5)
 ≥ 2 488 (19.0)
Unknown/not assessed 52 (2.0)
Number of tumors at most recent assessment, n (%)
 1 963 (37.7)
 2 − 7 1419 (55.6)
 > 8 172 (6.7)
Time since diagnosis (years), mean (SD) 1.9 (2.5)
Staging at diagnosis, n (%)
 CIS alone 871 (34.1)
 Papillary alone 859 (33.6)
 Papillary + CIS 824 (32.3)
  1. BMI: body mass index; CIS: carcinoma in situ; ECOG: Eastern Cooperative Oncology Group; NMIBC: non-muscle invasive bladder cancer; SD: standard deviation